Non-steroidal anti-inflammatory drug administration after coronary artery bypass surgery: utilization persists despite the boxed warning

Prevalence of and risk factors for persistent postoperative nonanginal pain after cardiac surgery: a 2-year prospective multicentre study

(2014) M. Choiniere et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Black Box Warning: Is Ketorolac Safe for Use After Cardiac Surgery?

(2013) Lisa Oliveri et al.   JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA

Comparative Effectiveness of Preventative Therapy for Venous Thromboembolism After Coronary Artery Bypass Graft Surgery

(2012) Alexander Kulik et al.   Circulation-Cardiovascular Interventions

Impact of Safety-Related Regulatory Action on Clinical Practice

(2012) Sigrid Piening et al.   DRUG SAFETY

Ketorolac Improves Graft Patency After Coronary Artery Bypass Grafting: A Propensity-Matched Analysis

(2011) Milo Engoren et al.   ANNALS OF THORACIC SURGERY

Cardiovascular Risks of Nonsteroidal Antiinflammatory Drugs in Patients After Hospitalization for Serious Coronary Heart Disease

(2009) Wayne A. Ray et al.  

Effects of Food and Drug Administration Warnings on Antidepressant Use in a National Sample

(2008) Mark Olfson et al.   ARCHIVES OF GENERAL PSYCHIATRY

Impact of Statin Use on Outcomes After Coronary Artery Bypass Graft Surgery

(2008) Alexander Kulik et al.   CIRCULATION